XML 60 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Schedule of Income Before Income Taxes
a.

Income before income taxes:

 

     Year ended December 31,  
     2018      2017      2016  
     (U.S. $ in millions)  

Parent Company and its Israeli subsidiaries

   $ 1,022      $ 1,451      $ 1,516  

Non-Israeli subsidiaries

     (3,618      (19,830      (692
  

 

 

    

 

 

    

 

 

 
   $ (2,596    $ (18,379    $ 824  
  

 

 

    

 

 

    

 

 

 

Schedule of the Provision for Income Taxes
b.

Income taxes:

 

     Year ended December 31,  
     2018      2017      2016  
     (U.S. $ in millions)  

In Israel

   $ 131      $ 96      $ 209  

Outside Israel

     (326      (2,029      312  
  

 

 

    

 

 

    

 

 

 
   $ (195    $ (1,933    $ 521  
  

 

 

    

 

 

    

 

 

 

Current

   $ 700      $ 373      $ 481  

Deferred

     (895      (2,306      40  
  

 

 

    

 

 

    

 

 

 
   $ (195    $ (1,933    $ 521  
  

 

 

    

 

 

    

 

 

 

Accumulated Other Comprehensive Income/(Loss) (Net of Tax)
     Year ended December 31,  
     2018     2017     2016  
     (U.S. $ in millions)  

Income (loss) before income taxes

   $ (2,596   $ (18,379   $ 824  

Statutory tax rate in Israel

     23.0     24.0     25.0
  

 

 

   

 

 

   

 

 

 

Theoretical provision for income taxes

   $ (597   $ (4,411   $ 206  

Increase (decrease) in effective tax rate due to:

      

The Parent Company and its Israeli subsidiaries—

      

Mainly tax benefits arising from reduced tax rates under benefit programs

     (134     (253     (212

Non-Israeli subsidiaries, including impairments (*)

     381       3,817       546  

U.S. Tax Cuts and Jobs Act effect

     97       (1,061     —    

Increase (decrease) in other uncertain tax positions—net

     58       (25     (19
  

 

 

   

 

 

   

 

 

 

Effective consolidated income taxes

   $ (195   $ (1,933   $ 521  
  

 

 

   

 

 

   

 

 

 

 

*

Income before income taxes includes goodwill impairment in non-Israeli subsidiaries that did not have a corresponding tax effect.

Schedule of Deferred Income Taxes
c.

Deferred income taxes:

 

    December 31,  
    2018      2017  
    (U.S. $ in millions)  

Long-term deferred tax assets (liabilities)—net:

 

Inventory related

  $ 113      $ 40  

Sales reserves and allowances

    199        201  

Provision for legal settlements

    42        171  

Intangible assets (*)

    (2,282      (3,132

Carryforward losses and deductions and credits (**)

    1,340        1,485  

Property, plant and equipment

    (167      (231

Deferred interest (***)

    391        —    

Provisions for employee related obligations

    102        142  

Other

    123        125  
 

 

 

    

 

 

 
    (139      (1,199

Valuation allowance—in respect of carryforward losses and deductions that may not be utilized (**)

    (1,633      (1,504
 

 

 

    

 

 

 
  $ (1,772    $ (2,703
 

 

 

    

 

 

 

 

*

The decrease in deferred tax liability is mainly due to impairment and amortization.

**

The amounts are shown after reduction for unrecognized tax benefits of $35 million and $26 million as of December 31, 2018 and 2017, respectively.

This amount represents the tax effect of gross carryforward losses and deductions with the following expirations: 2019-2021—$206 million; 2022-2028—$448 million; 2029 and thereafter—$280 million. The remaining balance—$441 million—can be utilized with no expiration date.

***

The increase in deferred tax asset is mainly due to the interest expense limitation following the enactment of the Tax Cuts and Jobs Act.

Schedule of Deferred Tax Assets and Liabilities By Report Caption

The deferred income taxes are reflected in the balance sheets among:

 

     December 31,  
     2018      2017  
     (U.S. $ in millions)  

Long-term assets—deferred income taxes

     368        574  

Long-term liabilities—deferred income taxes

     (2,140      (3,277
  

 

 

    

 

 

 
   $ (1,772    $ (2,703
  

 

 

    

 

 

Schedule of Unrecognized Tax Benefits

The following table summarizes the activity of Teva’s gross unrecognized tax benefits:

 

     Year ended December 31,  
     2018      2017      2016  
     (U.S. $ in millions)  

Balance at the beginning of the year

   $ 1,034      $ 734      $ 648  

Increase related to prior year tax positions, net

     76        56        23  

Increase related to current year tax positions

     11        26        71  

Decrease related to settlements with tax authorities and lapse of applicable statutes of limitations

     (49      (56      (103

Liabilities assumed in acquisitions

     —          273        101  

Other

     —          1        (6
  

 

 

    

 

 

    

 

 

 

Balance at the end of the year

   $ 1,072      $ 1,034      $ 734